期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

非肥胖糖尿病/重症联合免疫缺陷小鼠白血病微血管生成模型的建立 被引量：5

Construction of Microvessel Angiogenesis Model in Nonobese Diabetic/Severe Combined Immunodeficient Disease Leukemia Mice
在线阅读 下载PDF
导出
摘要 目的尝试建立非肥胖糖尿病/重症联合免疫缺陷(NOD/SCID)小鼠白血病微血管生成模型。方法NOD/SCID小鼠分为A组:空白对照组,B组:注射血管内皮细胞(EC)组,C组:建立白血病模型后注射EC组。通过免疫组织化学对NOD/SCID小鼠骨髓血管生成及全身肿瘤负荷情况进行评价。结果C组骨髓微血管密度明显>A、B组,白血病新生的微血管分支多紊乱,管腔较不规则,血管形态幼稚。结论成功建立NOD/SCID小鼠白血病微血管生成模型,可用于抗白血病血管生成及相关实验研究。 Objective To construct microvessel angiogenesis model in nonobese diabetic/severe combined immunodeficient disease（NOD/ SCID） leukemia mice. Methods Divided NOD/SCID mice into group A：blank group;group B：endothelial cell（EC） injection group;group C： leukemia model mice with EC injection group. Microvessel density（MVD） in bone marrow was calculated with cnemis slice after iwanunohistochemistry dyeing. Evaluated leukemia burden in leukemia model mice. Results Bone marrow MVD in group C was significantly more than group B. Microvessels in leukemia mice had disordered branches and irregular cavity. The morphism of vessels was immature. Conclusions Microvessel angingenesis model in NOD/SCID leukemia mice has been constructed successfully. It can be used in the study of anti - angingenesis in leukemia and relative researches.
作者 郭海霞 黎阳 邹燕琴 李文益
机构地区 中山大学附属第二医院儿科 中山大学附属第二医院科研科
出处 《实用儿科临床杂志》 CAS CSCD 北大核心 2007年第15期1172-1173,1196,共3页 Journal of Applied Clinical Pediatrics
基金 广东科技计划项目资助(2006B36301003)
关键词 血管生成 动物模型 白血病 angiogenesis animal model leukemia
分类号 R-332 [医药卫生]
  • 相关文献

参考文献11

  • 1Podar K,Anderson KC. The pathophysiolo gic role of VEGF in hematologic malignancies :Therapeutic implications [ J ]. Blood, 2005,105 (4) : 1383 - 1395.
  • 2Fragoso R, Pereira T, Wu Y ,et al. VEGFR - 1 ( FLT - 1 ) activation modulates acute lymphoblastic leukemia localization and survival within the bone marrow, determining the onset of extramedullary disease [ J ]. Blood,2006,107 (4) : 1608 - 1616.
  • 3Faderl S, Do KA ,Johnson MM ,et al. Angiogenic factors may have a different prognostic role in adult acute lymphoblastic leukemia [ J ]. Blood, 2005,106( 13 ) :4303 -4307.
  • 4Lyu CJ,Rha SY,Won SC. Clinical role of bone marrow angiogenesis in childhood acute lymphocytic leukemia[ J]. Yousei Med J, 2007,48 ( 2 ) : 171 - 175.
  • 5Szmigielska - Kaplon A, Jesionek - Kupnieka D, Gora - Tybor J, et al. Influence of cladfibine alone and in combinaton with cyclophosphamide or cyclophosphamide and mitoxantrone on bone marrow angiogenesis in chronic lymphocytic leukemia [ J ]. Leuk Lymphoma, 2007,48 ( 5 ) : 1042 -1044.
  • 6张育,顾健,王敏,马莉,王晓铃,何斌,孙梅.白血病患者血管新生及相关因素研究[J].中华血液学杂志,2005,26(3):175-178. 被引量：7
  • 7Scappaticci FA. Mechanisms and future directions for angiogenesis - based cancer therapies [ J ]. J Clin Oncol,2002,20 ( 18 ) :3906 - 3927.
  • 8许文林,沈慧玲,袁伟,王法春,江云伟.抗血管内皮生长因子发夹状核酶基因抑制白血病细胞裸鼠体内生长和肿瘤内血管生成[J].中华血液学杂志,2006,27(7):465-469. 被引量：2
  • 9Weidner N. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors [ J ]. Breast Cancer Res Treat,1995,36(2) :169 - 180.
  • 10Le Ricousse- Roussanne S, Barateau V, Contreres JO,et al. Ex vivo differentiated endothelial and smooth muscle cells from human cord blood progenitors home to the angiogenic tumor vasculature[ J]. Cardiovasc Res, 2004,62 ( 1 ) : 176 - 184.

二级参考文献17

  • 1Ohsugi T,Horie R,Kumasaka T,et al.In vivo antitumor activity of the NF-{kappa} B inhibitor dehydroxymethylepoxyquinomicin in a mouse model of adult T-cell[J].leukemia Carcinogenesis,2005;29(4):14-18.
  • 2Ninomiya M,Kiyoi H,Ito M,et al.Retinoic acid syndrome in NOD/scid mice induced by injecting an acute promyelocytic leukemia cell line[J].Leukemia,2004;18(3):442-448.
  • 3Tomkinson B,Bendele R,Giles FJ,et al.OSI-211,a novel liposomal topoisomerase I inhibitor,is active in SCID mouse models of human AML and ALL[J].Leuk Res,2003;27(11):1039-1050.
  • 4Claffey KP,Brown LF,del-Aguila LF,et al.Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth,angiogenesis,and experimental metastasis.Cancer Res,1996,56:172-181.
  • 5Bellamy WT,Richter L,Frutiger Y,et al.Expression of vascular endothelial growth factor and its receptors in hematopoietic malignances.Cancer Res,1999,59:728-733.
  • 6O' Neill B,Millington-Ward S,O' Reilly M,et al.Ribozyme-based therapeutic approaches for autosomal dominant retinitis pigmentosa.Invest Ophthalmol Vis Sci,2000,41:2863-2869.
  • 7Ehrenfried JA,Ko TC,Thompson EA,et al.Cell cycle-mediated regulation of hepatic regeneration.Surgery,1997,122:927-935.
  • 8Perez-Atayde AR,Sallan SE,Tedrow U,et al.Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia.Am J Pathol,1997,150:815-821.
  • 9Padro T,Ruiz S,Bicker R,et al.Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia.Blood,2000,95:2637 -2644.
  • 10Hussong JW,Rodgers GM,Shami PJ,et al.Evidence of increased angiogenesis in patients with acute myeloid leukemia.Blood,2000,95:309-313.

共引文献11

同被引文献101

引证文献5

二级引证文献18

实用儿科临床杂志
2007年 第15期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部